close

Fundraisings and IPOs

1 2 3 78
Number of results: 1543
Date Company Amount Funding type Investors Therapeutic area Type of Information
2019-05-28 Ideaya Biosciences (USA - CA) $57.5 million IPO Cancer - Oncology IPO
2019-05-22 Locana (USA - CA) $ 55 million series A financing round ARCH Venture Partners (USA) Temasek (Singapore) Lightstone Ventures (USA - MA) UCB Ventures (Belgium) GV (formerly Google Ventures) (USA - CA) Rare diseases - Genetic diseases Series A financing round
2019-03-20 Flagship Pioneering (USA - MA) $824 million financing round undisclosed long-time limited partners, new institutional investors, family offices Financing round
2019-03-14 Axovant Sciences (US - NY) $40 million private placement Rare diseases - Genetic diseases - Neurological diseases - Neuromuscular diseases Private placement
2019-03-13 Antisense Therapeutics (Australia) $1.6 million private placement Rare diseases - Genetic diseases Private placement
2019-03-11 Snipr Biome (Denmark) $50 million (€43 million, DKK320 million) series A financing round Lundbeckfonden Emerge (Denmark) LSP (Netherlands) North-East Family Office (Denmark) Wellington Partners (Germany) Autoimmune diseases - Cancer - Oncology - Infectious diseases Series A financing round
2019-03-06 Beam Therapeutics (USA - MA) $135 million series B financing round ARCH Venture Partners (USA - IL) F-Prime Capital Partners (USA - MA) Eight Roads Ventures (China - India - USA) Omega Funds (USA - MA) Redmile Group (USA - CA) Cormorant Asset Management (USA - MA) GV (USA - CA) Altitude Life Science Ventures (USA - WA) and additional undisclosed investors Rare diseases - Genetic diseases Series B financing round
2019-02-27 MeiraGTx (USA - NY) $80 million private placement Johnson & Johnson Innovation – JJDC (USA - NJ) Perceptive Advisors (USA - NY) OrbiMed Advisors, (USA - NY) 683 Capital Management (USA - NY) Rare diseases - Genetic diseases Private placement
2019-02-14 Passage Bio (USA - PA) $115.5 million series A financing round OrbiMed Advisors (USA - NY) Frazier Healthcare Partners (USA - WA) Versant Ventures (USA - CA) New Leaf Venture Partners (USA - NY - CA) Vivo Capital (USA - CA) Lilly Asia Ventures (China) Rare diseases - Genetic diseases - CNS diseases Series A financing round
2019-02-12 Neurogene (USA - NY) $68.5 million series A financing round Samsara BioCapital (USA - CA) EcoR1 Capital (USA - CA) Cormorant Asset Management (USA - MA) Redmile Group (USA - CA) undisclosed leading healthcare investment fund. Rare diseases - Genetic diseases - Neurological diseases Series A financing round
2019-01-25 Nordic Nanovector (Norway) NOK 222 million ($ 26 million) private placement Cancer - Oncology Private placement
2019-01-25 Corbus Pharmaceuticals (USA - MA) private placement Inflammatory diseases Private placement
2019-01-24 Wave Life Sciences (USA - MA) $150 million private placement Rare diseases - Genetic diseases Private placement
2019-01-24 Wave Life Sciences (USA - MA) $150 million private placement Rare diseases - Genetic diseases Private placement
2019-01-23 Orion (Finland) € 100 million loan European Investment Bank (EIB) Cancer - Oncology - Neurological diseases - Respiratory diseases Loan
2019-01-23 PTC Therapeutics (USA - NJ) private placement Rare diseases - Genetic diseases Private placement
2019-01-23 Selecta Biosciences (USA - MA) $30 million private placement Private placement
2019-01-22 Alvotech (Iceland) $300 million private placement Autoimmune diseases - Inflammatory diseases - Cancer - Oncology Private placement
2019-01-14 Alnylam Pharmaceuticals (USA - MA) $387.5 million private placement Rare diseases - Genetic diseases Private placement
2019-01-07 Apic Bio (USA-MA) $ 40 million series A financing round Morningside Venture Investments (China) The ALS Investment Fund (USA) The Alpha-1 Project (TAP) (USA - FL) A1ATD Investors (USA - MA) Rare diseases - Genetic diseases Series A financing round